chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Rash papular, Vaccination site erythema
Clinical narrative: raises area on the arm, that looks like a bulls eye; Raised area itches like an allergic reaction; Raised area is red; This spontaneous case was reported by a consumer and describes the occurrence of RASH PAPULAR (raises area on the arm, that looks like a bulls eye), HYPERSENSITIVITY (Raised area itches like an allergic reaction) and VACCINATION SITE ERYTHEMA (Raised area is red) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced RASH PAPULAR (raises area on the arm, that looks like a bulls eye), HYPERSENSITIVITY (Raised area itches like an allergic reaction) and VACCINATION SITE ERYTHEMA (Raised area is red). At the time of the report, RASH PAPULAR (raises area on the arm, that looks like a bulls eye), HYPERSENSITIVITY (Raised area itches like an allergic reaction) and VACCINATION SITE ERYTHEMA (Raised area is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided.  Treatment of these medications were not reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: itchy; vaccination site is very red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (vaccination site is very red) and VACCINATION SITE PRURITUS (itchy) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (vaccination site is very red) and VACCINATION SITE PRURITUS (itchy). At the time of the report, VACCINATION SITE ERYTHEMA (vaccination site is very red) and VACCINATION SITE PRURITUS (itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old received vaccine; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received vaccine) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  Company comment: This report refers to a case of Product Administered to Patient of Inappropriate Age for mRNA-1273 (Lot number: Unknown) with no associated AEs.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Myalgia, Vaccination site pain
Clinical narrative: Elevated blood sugar levels; Tenderness at site of injection; Body ache from head to toe; A spontaneous report was received from a consumer who was a 73-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and who experienced elevated blood sugar levels, body ache from head to toe and tenderness at the site of injection.  The patient's medical history included Type 1 Diabetes Mellitus, insulin dependent. Concomitant medications reported were rosuvastatin, losartan, levothyroxine and insulin.  On 7 Mar 2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (lot/batch: 029A21A) intramuscularly for prophylaxis of COVID-19 infection.  On 8 Mar 2021, the patient experienced elevated blood sugar levels.  She reported that she was requiring triple the amount of her usual insulin dose.  She felt her situation was very dangerous.  Also, she reported tenderness at the site of injection and a body ache from head to toe.  Treatment included Insulin for the elevated blood glucose and ice for the tender injection site.  The patient received both scheduled doses of mRNA-1273, therefore, action taken with mRNA-1273 in response to the events was not applicable.   The outcomes of events, elevated blood sugar levels, body ache from head to toe and  tenderness at the site of injection, were considered unknown.; Reporter's Comments: The events were consistent with increased risk of complications associated with history of diabetes, confounded by elderly age of patient. Company assessed the events to be unlikely related to company product.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Fatigue, Headache, Palpitations
Clinical narrative: Weak / no energy; Palpitations; Feeling tired; Headachy; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak / no energy), PALPITATIONS (Palpitations), FATIGUE (Feeling tired) and HEADACHE (Headachy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATENOLOL, ESCITALOPRAM OXALATE (LEXAPRO), ATORVASTATIN, LEVOTHYROXINE SODIUM (SYNTHROID) and OMEPRAZOLE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced ASTHENIA (Weak / no energy), PALPITATIONS (Palpitations), FATIGUE (Feeling tired) and HEADACHE (Headachy). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, ASTHENIA (Weak / no energy), PALPITATIONS (Palpitations), FATIGUE (Feeling tired) and HEADACHE (Headachy) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, COVID-19: negative negative Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Dyspnoea, Headache, Hyperhidrosis
Clinical narrative: having trouble breathing; low grade fever; headache; Chills; sweat; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweat), DYSPNOEA (having trouble breathing), CHILLS (Chills), PYREXIA (low grade fever) and HEADACHE (headache) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN and FLUOXETINE HYDROCHLORIDE (PROZAC) for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced HYPERHIDROSIS (sweat) and CHILLS (Chills). On 07-Mar-2021, the patient experienced HEADACHE (headache). On an unknown date, the patient experienced DYSPNOEA (having trouble breathing) and PYREXIA (low grade fever). At the time of the report, HYPERHIDROSIS (sweat), DYSPNOEA (having trouble breathing), CHILLS (Chills), PYREXIA (low grade fever) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: having trouble breathing; low grade fever; headache; Chills; sweat; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweat), DYSPNOEA (having trouble breathing), CHILLS (Chills), PYREXIA (low grade fever) and HEADACHE (headache) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN and FLUOXETINE HYDROCHLORIDE (PROZAC) for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced HYPERHIDROSIS (sweat) and CHILLS (Chills). On 07-Mar-2021, the patient experienced HEADACHE (headache). On an unknown date, the patient experienced DYSPNOEA (having trouble breathing) and PYREXIA (low grade fever). At the time of the report, HYPERHIDROSIS (sweat), DYSPNOEA (having trouble breathing), CHILLS (Chills), PYREXIA (low grade fever) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Cough, Dyspnoea, Feeling hot
Clinical narrative: Nose is stuffed up; headache; she had chills; Sweating a lot; Felt like her chest was on fire; felt weak; Shortness of breath; Felt hot and cold; Coughing so much it hurt; This spontaneous case was reported by a patient and describes the occurrence of COUGH (Coughing so much it hurt), FEELING HOT (Felt like her chest was on fire), ASTHENIA (felt weak), DYSPNOEA (Shortness of breath) and FEELING OF BODY TEMPERATURE CHANGE (Felt hot and cold) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included IBUPROFEN and GABAPENTIN for an unknown indication.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced COUGH (Coughing so much it hurt) and FEELING OF BODY TEMPERATURE CHANGE (Felt hot and cold). On 08-Mar-2021, the patient experienced FEELING HOT (Felt like her chest was on fire), ASTHENIA (felt weak), DYSPNOEA (Shortness of breath), HYPERHIDROSIS (Sweating a lot) and CHILLS (she had chills). On 09-Mar-2021, the patient experienced NASAL CONGESTION (Nose is stuffed up) and HEADACHE (headache). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency and GUAIFENESIN (MUCINEX) at an unspecified dose and frequency. At the time of the report, COUGH (Coughing so much it hurt), FEELING HOT (Felt like her chest was on fire), ASTHENIA (felt weak), DYSPNOEA (Shortness of breath), FEELING OF BODY TEMPERATURE CHANGE (Felt hot and cold), HYPERHIDROSIS (Sweating a lot), NASAL CONGESTION (Nose is stuffed up), HEADACHE (headache) and CHILLS (she had chills) outcome was unknown. Unknown          Concomitant medication also include hypertension pills.  Action taken with mRNA-123 is not applicable.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling of body temperature change, Headache, Hyperhidrosis, Nasal congestion
Clinical narrative: Nose is stuffed up; headache; she had chills; Sweating a lot; Felt like her chest was on fire; felt weak; Shortness of breath; Felt hot and cold; Coughing so much it hurt; This spontaneous case was reported by a patient and describes the occurrence of COUGH (Coughing so much it hurt), FEELING HOT (Felt like her chest was on fire), ASTHENIA (felt weak), DYSPNOEA (Shortness of breath) and FEELING OF BODY TEMPERATURE CHANGE (Felt hot and cold) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included IBUPROFEN and GABAPENTIN for an unknown indication.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced COUGH (Coughing so much it hurt) and FEELING OF BODY TEMPERATURE CHANGE (Felt hot and cold). On 08-Mar-2021, the patient experienced FEELING HOT (Felt like her chest was on fire), ASTHENIA (felt weak), DYSPNOEA (Shortness of breath), HYPERHIDROSIS (Sweating a lot) and CHILLS (she had chills). On 09-Mar-2021, the patient experienced NASAL CONGESTION (Nose is stuffed up) and HEADACHE (headache). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency and GUAIFENESIN (MUCINEX) at an unspecified dose and frequency. At the time of the report, COUGH (Coughing so much it hurt), FEELING HOT (Felt like her chest was on fire), ASTHENIA (felt weak), DYSPNOEA (Shortness of breath), FEELING OF BODY TEMPERATURE CHANGE (Felt hot and cold), HYPERHIDROSIS (Sweating a lot), NASAL CONGESTION (Nose is stuffed up), HEADACHE (headache) and CHILLS (she had chills) outcome was unknown. Unknown          Concomitant medication also include hypertension pills.  Action taken with mRNA-123 is not applicable.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 and a half years patient received first dose; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 and a half years patient received first dose) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included ALBUTEROL [SALBUTAMOL] for Asthma.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 and a half years patient received first dose). On 04-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 and a half years patient received first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: Follow-up received on 31 Mar 2021 included the outcome of event Inappropriate age at vaccine administration was resolved on 4-Mar-2021; Sender's Comments: This report refers to a case of inappropriate age at vaccine administration for mRNA-1273, lot # 027A21A  with no associated AEs.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Hyperhidrosis
Clinical narrative: Weak; Light headed; Sweating bad; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak), DIZZINESS (Light headed) and HYPERHIDROSIS (Sweating bad) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 01-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weak), DIZZINESS (Light headed) and HYPERHIDROSIS (Sweating bad). At the time of the report, ASTHENIA (Weak), DIZZINESS (Light headed) and HYPERHIDROSIS (Sweating bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment information was not provided.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Laryngitis, Oral mucosal eruption
Clinical narrative: rash on side of mouth; Slight cough; Laryngitis; This spontaneous case was reported by an other health care professional and describes the occurrence of ORAL MUCOSAL ERUPTION (rash on side of mouth), COUGH (Slight cough) and LARYNGITIS (Laryngitis) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy (Banana), Allergy (Plant) and Drug allergy.    In March 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced COUGH (Slight cough) and LARYNGITIS (Laryngitis). On an unknown date, the patient experienced ORAL MUCOSAL ERUPTION (rash on side of mouth). At the time of the report, ORAL MUCOSAL ERUPTION (rash on side of mouth) had resolved and COUGH (Slight cough) and LARYNGITIS (Laryngitis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported .  No treatment medication reported.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: pruritus; rash all over body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (pruritus) and RASH (rash all over body) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Varicella (history of chicken pox), Shingles (Patient had shingles injection two years ago.) and Open heart surgery (Heart surgery in 2005) in 2005.   On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced PRURITUS (pruritus) and RASH (rash all over body). At the time of the report, PRURITUS (pruritus) and RASH (rash all over body) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: No new information; Reporter's Comments: Crosslink: MOD21-050383 Patient calling back about paperwork he received in the mail from a prior adverse event he reported. Crosslinked case and updated contact information.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash erythematous
Clinical narrative: itches like crazy (rash); red(rash); rash all over body after 1st dose, on her chest, face, back and arms; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itches like crazy (rash)), RASH ERYTHEMATOUS (red(rash)) and RASH (rash all over body after 1st dose, on her chest, face, back and arms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022m20a) for COVID-19 vaccination.     No medical history reported.     On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itches like crazy (rash)), RASH ERYTHEMATOUS (red(rash)) and RASH (rash all over body after 1st dose, on her chest, face, back and arms). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for Adverse event, at an unspecified dose and frequency. At the time of the report, PRURITUS (itches like crazy (rash)) had not resolved and RASH ERYTHEMATOUS (red(rash)) and RASH (rash all over body after 1st dose, on her chest, face, back and arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Non significant follow up received on 24-may-2021, event was ongoing.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Facial discomfort, Throat tightness
Clinical narrative: Muscles in throat were tense; Face felt funny; This spontaneous case was reported by a patient and describes the occurrence of THROAT TIGHTNESS (Muscles in throat were tense) and FACIAL DISCOMFORT (Face felt funny) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023m20a and 006321A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included LOVASTATIN, LEVOTHYROXINE SODIUM (SYNTHROID) and AMITRIPTYLINE for an unknown indication.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced THROAT TIGHTNESS (Muscles in throat were tense) and FACIAL DISCOMFORT (Face felt funny). At the time of the report, THROAT TIGHTNESS (Muscles in throat were tense) and FACIAL DISCOMFORT (Face felt funny) outcome was unknown. Not Provided          Concomitant medications also included unspecified blood pressure medication. Treatment information was not provided. Action taken with mRNA-123 is not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: information regarding 2nd dose added. action taken was updated.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain in extremity, Peripheral coldness
Clinical narrative: Limbs feel cold; Limbs were hurting; Feeling a little Chilly; Minor headache; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL COLDNESS (Limbs feel cold), PAIN IN EXTREMITY (Limbs were hurting), CHILLS (Feeling a little Chilly) and HEADACHE (Minor headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL COLDNESS (Limbs feel cold), PAIN IN EXTREMITY (Limbs were hurting), CHILLS (Feeling a little Chilly) and HEADACHE (Minor headache). At the time of the report, PERIPHERAL COLDNESS (Limbs feel cold), PAIN IN EXTREMITY (Limbs were hurting), CHILLS (Feeling a little Chilly) and HEADACHE (Minor headache) outcome was unknown.            No Concomitant medication were provided by the reporter. No treatment medication was provided by the reporter. Action taken with mRNA-123 is not applicable.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Oral mucosal blistering
Clinical narrative: Blister all over tongue; This spontaneous case was reported by a consumer and describes the occurrence of ORAL MUCOSAL BLISTERING (Blister all over tongue) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced ORAL MUCOSAL BLISTERING (Blister all over tongue). At the time of the report, ORAL MUCOSAL BLISTERING (Blister all over tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included None.   Reporter did not allow further contact
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, COVID-19, Chills, Gait disturbance, Insomnia
Clinical narrative: Tested positive for COVID-19; Horrible pain in her arm that did not let her move it, she could not rise her hand; Did not let her move it, she could not rise her hand; Nor sleep well; Fever in the mornings but not at night; Chills; She could not walk.; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), GAIT DISTURBANCE (She could not walk.), COVID-19 (Tested positive for COVID-19), PAIN IN EXTREMITY (Horrible pain in her arm that did not let her move it, she could not rise her hand) and MOBILITY DECREASED (Did not let her move it, she could not rise her hand) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Nasal congestion (Congestion) on 04-Mar-2021, Anosmia (The patient can't smell well because of the congestion) on 04-Mar-2021 and Cough on 04-Mar-2021.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced CHILLS (Chills), GAIT DISTURBANCE (She could not walk.), PAIN IN EXTREMITY (Horrible pain in her arm that did not let her move it, she could not rise her hand), MOBILITY DECREASED (Did not let her move it, she could not rise her hand), INSOMNIA (Nor sleep well) and PYREXIA (Fever in the mornings but not at night). On 07-Mar-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, CHILLS (Chills), GAIT DISTURBANCE (She could not walk.), COVID-19 (Tested positive for COVID-19), INSOMNIA (Nor sleep well) and PYREXIA (Fever in the mornings but not at night) outcome was unknown and PAIN IN EXTREMITY (Horrible pain in her arm that did not let her move it, she could not rise her hand) and MOBILITY DECREASED (Did not let her move it, she could not rise her hand) was resolving. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Body temperature increased: 100.4 (Inconclusive) Reached a temperature of 100.4°F, then 99.4°F. On 07-Mar-2021, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment for the events included medicine for fever.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Pain in extremity, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID-19; Horrible pain in her arm that did not let her move it, she could not rise her hand; Did not let her move it, she could not rise her hand; Nor sleep well; Fever in the mornings but not at night; Chills; She could not walk.; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), GAIT DISTURBANCE (She could not walk.), COVID-19 (Tested positive for COVID-19), PAIN IN EXTREMITY (Horrible pain in her arm that did not let her move it, she could not rise her hand) and MOBILITY DECREASED (Did not let her move it, she could not rise her hand) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Nasal congestion (Congestion) on 04-Mar-2021, Anosmia (The patient can't smell well because of the congestion) on 04-Mar-2021 and Cough on 04-Mar-2021.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced CHILLS (Chills), GAIT DISTURBANCE (She could not walk.), PAIN IN EXTREMITY (Horrible pain in her arm that did not let her move it, she could not rise her hand), MOBILITY DECREASED (Did not let her move it, she could not rise her hand), INSOMNIA (Nor sleep well) and PYREXIA (Fever in the mornings but not at night). On 07-Mar-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, CHILLS (Chills), GAIT DISTURBANCE (She could not walk.), COVID-19 (Tested positive for COVID-19), INSOMNIA (Nor sleep well) and PYREXIA (Fever in the mornings but not at night) outcome was unknown and PAIN IN EXTREMITY (Horrible pain in her arm that did not let her move it, she could not rise her hand) and MOBILITY DECREASED (Did not let her move it, she could not rise her hand) was resolving. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Body temperature increased: 100.4 (Inconclusive) Reached a temperature of 100.4°F, then 99.4°F. On 07-Mar-2021, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment for the events included medicine for fever.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dehydration, Diarrhoea, Fatigue, Flatulence
Clinical narrative: diarrhea; gas; cramps; dehydrated,; being tired; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), FLATULENCE (gas), MUSCLE SPASMS (cramps), DEHYDRATION (dehydrated,) and FATIGUE (being tired) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Rheumatoid arthritis (which is controlled). Concomitant products included LEVOTHYROXINE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DIARRHOEA (diarrhea), FLATULENCE (gas), MUSCLE SPASMS (cramps), DEHYDRATION (dehydrated,), FATIGUE (being tired) and CHILLS (chills). At the time of the report, DIARRHOEA (diarrhea), FLATULENCE (gas), MUSCLE SPASMS (cramps), DEHYDRATION (dehydrated,), FATIGUE (being tired) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information includes took something for diarrhea and drinking water.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: diarrhea; gas; cramps; dehydrated,; being tired; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), FLATULENCE (gas), MUSCLE SPASMS (cramps), DEHYDRATION (dehydrated,) and FATIGUE (being tired) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Rheumatoid arthritis (which is controlled). Concomitant products included LEVOTHYROXINE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DIARRHOEA (diarrhea), FLATULENCE (gas), MUSCLE SPASMS (cramps), DEHYDRATION (dehydrated,), FATIGUE (being tired) and CHILLS (chills). At the time of the report, DIARRHOEA (diarrhea), FLATULENCE (gas), MUSCLE SPASMS (cramps), DEHYDRATION (dehydrated,), FATIGUE (being tired) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information includes took something for diarrhea and drinking water.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal discomfort, Eye pain, Pruritus
Clinical narrative: eye pain after receiving the vaccine; on stop gastro-intestinal problems; arms itches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (eye pain after receiving the vaccine), ABDOMINAL DISCOMFORT (on stop gastro-intestinal problems) and PRURITUS (arms itches) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EYE PAIN (eye pain after receiving the vaccine), ABDOMINAL DISCOMFORT (on stop gastro-intestinal problems) and PRURITUS (arms itches). At the time of the report, EYE PAIN (eye pain after receiving the vaccine), ABDOMINAL DISCOMFORT (on stop gastro-intestinal problems) and PRURITUS (arms itches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment medication was reported.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Swollen tongue
Clinical narrative: Swollen Tongue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWOLLEN TONGUE (Swollen Tongue) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced SWOLLEN TONGUE (Swollen Tongue). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. On 16-Feb-2021, SWOLLEN TONGUE (Swollen Tongue) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment includes diphenhydramine hydrochloride (Benadryl ) and it helped to get the swelling down.
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dysgeusia, Fatigue, Tongue ulceration, Vaccination site pain
Clinical narrative: Anxiety; Rash increasing from 1' to 3" left arm; Fatigue; Stronger pain at injection site (LEFT); Pain at injection site (LEFT); Taste metal; Tongue ulcers; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSGEUSIA (Taste metal), TONGUE ULCERATION (Tongue ulcers), ANXIETY (Anxiety), FATIGUE (Fatigue) and VACCINATION SITE RASH (Rash increasing from 1' to 3" left arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.     On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced DYSGEUSIA (Taste metal), TONGUE ULCERATION (Tongue ulcers) and VACCINATION SITE PAIN (Pain at injection site (LEFT)). On 07-Mar-2021, the patient experienced VACCINATION SITE PAIN (Stronger pain at injection site (LEFT)). On 08-Mar-2021, the patient experienced FATIGUE (Fatigue). On 09-Mar-2021, the patient experienced VACCINATION SITE RASH (Rash increasing from 1' to 3" left arm). On an unknown date, the patient experienced ANXIETY (Anxiety). On 10-Mar-2021, DYSGEUSIA (Taste metal), VACCINATION SITE PAIN (Pain at injection site (LEFT)) and VACCINATION SITE PAIN (Stronger pain at injection site (LEFT)) had resolved. At the time of the report, TONGUE ULCERATION (Tongue ulcers), ANXIETY (Anxiety), FATIGUE (Fatigue) and VACCINATION SITE RASH (Rash increasing from 1' to 3" left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Anxiety; Rash increasing from 1' to 3" left arm; Fatigue; Stronger pain at injection site (LEFT); Pain at injection site (LEFT); Taste metal; Tongue ulcers; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSGEUSIA (Taste metal), TONGUE ULCERATION (Tongue ulcers), ANXIETY (Anxiety), FATIGUE (Fatigue) and VACCINATION SITE RASH (Rash increasing from 1' to 3" left arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.     On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced DYSGEUSIA (Taste metal), TONGUE ULCERATION (Tongue ulcers) and VACCINATION SITE PAIN (Pain at injection site (LEFT)). On 07-Mar-2021, the patient experienced VACCINATION SITE PAIN (Stronger pain at injection site (LEFT)). On 08-Mar-2021, the patient experienced FATIGUE (Fatigue). On 09-Mar-2021, the patient experienced VACCINATION SITE RASH (Rash increasing from 1' to 3" left arm). On an unknown date, the patient experienced ANXIETY (Anxiety). On 10-Mar-2021, DYSGEUSIA (Taste metal), VACCINATION SITE PAIN (Pain at injection site (LEFT)) and VACCINATION SITE PAIN (Stronger pain at injection site (LEFT)) had resolved. At the time of the report, TONGUE ULCERATION (Tongue ulcers), ANXIETY (Anxiety), FATIGUE (Fatigue) and VACCINATION SITE RASH (Rash increasing from 1' to 3" left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: several cowerkers had side effects after vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (several cowerkers had side effects after vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (several cowerkers had side effects after vaccination). At the time of the report, ADVERSE EVENT (several cowerkers had side effects after vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.        Information about concomitant medications was not reported. No treatment information as provided. This case was linked to MOD21-049967 (E2B Linked Report).   This case was linked to MOD21-049967 (E2B Linked Report).; Sender's Comments:  MOD21-049967:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Vaccination site pain
Clinical narrative: Sore arm; Vaccination site pain; little headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PAIN (Vaccination site pain) and HEADACHE (little headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PAIN (Vaccination site pain) and HEADACHE (little headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PAIN (Vaccination site pain) and HEADACHE (little headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment medicines include Tylenol for Pain relief.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: swelling under jaw bone the size of a golf ball; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (swelling under jaw bone the size of a golf ball) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 007M20A) for COVID-19 vaccination.     The patient's past medical history included Knee pain (bad knee) and Surgery (2 artificial hips).   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced SWELLING FACE (swelling under jaw bone the size of a golf ball). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency and Manual therapy (Ice pack) for Swelling face. At the time of the report, SWELLING FACE (swelling under jaw bone the size of a golf ball) had not resolved. Unknown          The action taken for m-RNA 1273  moderna  COVID -19 vaccine was not applicable.  No concomitant medications were provided  Treatment therapy included ice pack.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow up document received on 23-JUN-2021 and contains no new information.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Electrocardiogram, Feeling abnormal, Myalgia, Urine analysis
Clinical narrative: injection site reaction; Last two days "feeling bad; pain in left arm, heart area and ribs, bottom; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (injection site reaction), FEELING ABNORMAL (Last two days "feeling bad) and MYALGIA (pain in left arm, heart area and ribs, bottom) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE REACTION (injection site reaction), FEELING ABNORMAL (Last two days "feeling bad) and MYALGIA (pain in left arm, heart area and ribs, bottom). At the time of the report, VACCINATION SITE REACTION (injection site reaction), FEELING ABNORMAL (Last two days "feeling bad) and MYALGIA (pain in left arm, heart area and ribs, bottom) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: Normal. On an unknown date, Electrocardiogram: normal. On an unknown date, Urine analysis: Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       patient reported experienced no symptoms from his first dose of Moderna covid-19 vaccine but after 24 days he experienced injection site reaction, last two days "feeling bad", pain in left arm, heart area and ribs, bottom. He reported his GP ruled out any problem heart related stuff, yesterday took blood work, urinalysis and EKG and nothing came out.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: injection site reaction; Last two days "feeling bad; pain in left arm, heart area and ribs, bottom; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (injection site reaction), FEELING ABNORMAL (Last two days "feeling bad) and MYALGIA (pain in left arm, heart area and ribs, bottom) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE REACTION (injection site reaction), FEELING ABNORMAL (Last two days "feeling bad) and MYALGIA (pain in left arm, heart area and ribs, bottom). At the time of the report, VACCINATION SITE REACTION (injection site reaction), FEELING ABNORMAL (Last two days "feeling bad) and MYALGIA (pain in left arm, heart area and ribs, bottom) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: Normal. On an unknown date, Electrocardiogram: normal. On an unknown date, Urine analysis: Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       patient reported experienced no symptoms from his first dose of Moderna covid-19 vaccine but after 24 days he experienced injection site reaction, last two days "feeling bad", pain in left arm, heart area and ribs, bottom. He reported his GP ruled out any problem heart related stuff, yesterday took blood work, urinalysis and EKG and nothing came out.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Hyperhidrosis, SARS-CoV-2 antibody test
Clinical narrative: sweating for 1hs and 2hs in my sleep, like from my waist to my neck; Felt very tired, fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating for 1hs and 2hs in my sleep, like from my waist to my neck) and FATIGUE (Felt very tired, fatigue) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient already had COVID-19 a couple of months ago, finished with it on December 7th or 8th.) in December 2020. Concurrent medical conditions included Hypertension.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced FATIGUE (Felt very tired, fatigue). On 08-Mar-2021, the patient experienced HYPERHIDROSIS (sweating for 1hs and 2hs in my sleep, like from my waist to my neck). On 06-Mar-2021, FATIGUE (Felt very tired, fatigue) had resolved. At the time of the report, HYPERHIDROSIS (sweating for 1hs and 2hs in my sleep, like from my waist to my neck) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 antibody test: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Treatment information was not provided.